다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Dicerna Pharmaceuticals Inc (DRNA)
Dicerna Pharmaceuticals Inc (DRNA) 뉴스

DRNA

Dicerna Pharmaceuticals (DRNA)

Dicerna Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DRNA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/24	21:00	GlobeNewswire Inc.	Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2022/02/14	20:18	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2022/01/11	07:00	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2022/01/03	20:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/30	06:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/29	01:18	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/29	01:15	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/29	01:14	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/29	01:12	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/29	01:11	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/29	01:06	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/29	01:04	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/29	00:52	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/29	00:47	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/28	23:35	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/28	23:29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/28	23:04	Business Wire	Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/27	22:08	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc
2021/12/27	22:01	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:DRNA	Dicerna Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:DRNA

1 2 3 4 5 6 7 8 9 10 다음 >>

Health Care Select Sector

Energy Select Sector SPDR

JP Morgan Chase

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관